UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

771 Preliminary Analysis of RTOG 9508: A Phase III Prospective Randomized Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Brain Metastases

Neurosurgery, 2000-08, Vol.47 (2), p.520-520

2000

Volltextzugriff (PDF)

Abstract 736: RTOG 0320:A phase III trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.736-736

2012

Volltextzugriff (PDF)

The accuracy of predicting survival in individual patients with cancer

Journal of neurosurgery, 2014-01, Vol.120 (1), p.24-30

2014

Volltextzugriff (PDF)

The accuracy of predicting survival in individual patients with cancer: Clinical article

Journal of neurosurgery, 2014-01, Vol.120 (1), p.24-30

2014

Volltextzugriff (PDF)

ACTR-38. NRG/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi10-vi10

2016

Volltextzugriff (PDF)

Adjuvant radiation, androgen deprivation, and docetaxel for high-risk prostate cancer post-prostatectomy: Results of RTOG 0621

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5031-5031

2014

Volltextzugriff (PDF)

Adjuvant Radiation Therapy, Androgen Deprivation and Docetaxel for High-risk Prostate Cancer Post-prostatectomy: Results of NRG Oncology RTOG 0621

Cancer, 2017-03, Vol.123 (13), p.2489-2496

2017

Volltextzugriff (PDF)

The Age-related Eye Disease Study 2 (AREDS2)

Ophthalmology (Rochester, Minn.), 2012-11, Vol.119 (11), p.2282-2289

2012

Volltextzugriff (PDF)

The Age-related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1 )

Ophthalmology (Rochester, Minn.), 2012-11, Vol.119 (11), p.2282-2289

2012

Volltextzugriff (PDF)

The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4

American journal of ophthalmology, 2001-02, Vol.131 (2), p.167-175

2001

Volltextzugriff (PDF)

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

International journal of radiation oncology, biology, physics, 2020-06, Vol.107 (2), p.334-343

2020

Volltextzugriff (PDF)

BM-13 THE (F)UTILITY OF PREDICTIVE MODELS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v34-v35

2014

Volltextzugriff (PDF)

BM-13THE (F)UTILITY OF PREDICTIVE MODELS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v34-v35

2014

Volltextzugriff (PDF)

BM-38 THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v40-v40

2014

Volltextzugriff (PDF)

BM-38THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v40-v40

2014

Volltextzugriff (PDF)

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi27-vi27

2016

Volltextzugriff (PDF)

BMET-20RTOG1119 PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v49.2-v49

2015

Volltextzugriff (PDF)

Brain Metastases in Lung Cancer With Targetable Mutations-Reply

JAMA oncology, 2018-03, Vol.4 (3), p.422

2018

Volltextzugriff (PDF)

Brain Metastasis—A Multidisciplinary Approach

International Journal of Radiation Oncology, Biology, Physics, 2009, Vol.75 (4), p.1273-1273

Sperduto, Paul W., M.D., M.P.P

2009

Volltextzugriff (PDF)

Cancer Prevention and Control Committee

International journal of radiation oncology, biology, physics, 2001, Vol.51 (3), p.113-119

Cancer Prevention and Control Committee Key Members

2001

Volltextzugriff (PDF)

Classification of Brain Metastases

Central Nervous System Metastases, p.83-93

Volltextzugriff (PDF)

COMPARABILITY OF OPHTHALMIC DIAGNOSES BY CLINICAL AND READING CENTER EXAMINERS IN THE VISUAL ACUITY IMPAIRMENT SURVEY PILOT STUDY

American journal of epidemiology, 1986-12, Vol.124 (6), p.994-1003

1986

Volltextzugriff (PDF)

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.1391-1401

2024

Volltextzugriff (PDF)

The cost-effectiveness of alternative treatments in prostate cancer

International journal of radiation oncology, biology, physics, 1994, Vol.30, p.220-220

1994

Volltextzugriff (PDF)

CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii42-ii42

2020

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Series

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(110)
Buchkapitel
(4)

Sprache

Englisch
(114)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(64)
Oncology
(50)
Aged
(36)
Female
(35)
Middle Aged
(34)
Male
(31)
Prognosis
(30)
Brain Neoplasms - Secondary
(27)
Radiology, Nuclear Medicine & Medical Imaging
(26)
Aged, 80 And Over
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Adult
(18)
Brain Neoplasms - Mortality
(18)
Hematology, Oncology And Palliative Medicine
(18)
Radiology
(18)
Retrospective Studies
(17)
Brain Metastases
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

771 Preliminary Analysis of RTOG 9508: A Phase III Prospective Randomized Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Brain Metastases

Abstract 736: RTOG 0320:A phase III trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases

The accuracy of predicting survival in individual patients with cancer

The accuracy of predicting survival in individual patients with cancer: Clinical article

ACTR-38. NRG/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Adjuvant radiation, androgen deprivation, and docetaxel for high-risk prostate cancer post-prostatectomy: Results of RTOG 0621

Adjuvant Radiation Therapy, Androgen Deprivation and Docetaxel for High-risk Prostate Cancer Post-prostatectomy: Results of NRG Oncology RTOG 0621

The Age-related Eye Disease Study 2 (AREDS2)

The Age-related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1 )

The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

BM-13 THE (F)UTILITY OF PREDICTIVE MODELS

BM-13THE (F)UTILITY OF PREDICTIVE MODELS

BM-38 THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

BM-38THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

BMET-20RTOG1119 PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Brain Metastases in Lung Cancer With Targetable Mutations-Reply

Brain Metastasis—A Multidisciplinary Approach

Cancer Prevention and Control Committee

Classification of Brain Metastases

COMPARABILITY OF OPHTHALMIC DIAGNOSES BY CLINICAL AND READING CENTER EXAMINERS IN THE VISUAL ACUITY IMPAIRMENT SURVEY PILOT STUDY

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial

The cost-effectiveness of alternative treatments in prostate cancer

CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER

Aktive Filter

Suchergebnisse filtern